We are pleased to welcome our new COO for AET Laboratories, Sandip Tarate, to Tiefenbacher Group.
Sandip has joined our site in Hyderabad, India, with 23+ years of extensive experience in the pharmaceutical sector. Furthermore, to induct and orient Sandip to Tiefenbacher family, our Managing Director Kristian Ruepp has visited our plant in Hyderabad. Therefore we ensure a great employee on-boarding experience.
Later, in view of Sandip’s first day, Kristian has hosted an inspiring town hall meeting underscoring the importance of the value system in our organization. We are energized about the path ahead for AET Laboratories, our customers, and our partners.
This is currently an exciting phase in our growth journey. The photo below shows the management team with our colleagues from the construction site extension in front of the newly built High Potent block. Undoubtedly this is proof that resilience and teamwork can work wonders!
The completion of the new building is the first step for Tiefenbacher Group to become a leading global developer and manufacturer of highly potent drugs for the treatment of cancer and other diseases. It follows our company´s strategy to make medicines more affordable, more available, and better than before.
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com
